Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

A North Yorkshire hospital has introduced AI technology that could speed up the detection of lung cancer and other serious ...

Bouaynaya’s appointment represents a significant investment in leveraging AI to drive Rowan University's strategic growth. As ...

Raj Toleti, CEO and chairman of Andor Health, guides the company’s vision to improve hospital and provider systems.

The words "artificial intelligence" are now ubiquitous, their influence having risen dramatically in recent years and their ...

Two final-year Medicine students design consultation tools thanks to a grant from the Cris Foundation against Cancer. After a cancer diagnosis, it is inevitable to type the type on the internet and ...